8-K: SS Innovations International to Ring Nasdaq Opening Bell, Celebrates 4,000 Robotic Surgeries Milestone

SS Innovations International, Inc. announced it will ring the Nasdaq Opening Bell on June 3, 2025, celebrating its recent Nasdaq uplisting and the completion of over 4,000 robotic surgeries with its SSi Mantra system.

Summary

• SS Innovations International, Inc. (Nasdaq: SSII) will ring the Nasdaq Opening Bell at the Nasdaq MarketSite in New York City on Tuesday, June 3, 2025, at 9:15 a.m. Eastern Time.
• The event commemorates the Company's April 2025 uplisting of its common stock to Nasdaq.
• The Company is also celebrating the successful completion of over 4,000 robotic surgeries using its SSi Mantra system across more than 100 types of surgeries, without any reported complications, injuries, or mortalities.
• The SSi Mantra system has achieved growing acceptance among physicians in India and six other countries.
• SS Innovations plans to introduce the SSi Mantra system in new global markets, including the European Union and the United States, to make robotic surgery more affordable and accessible.

Sentiment

Score: 8

Explanation: The document conveys a highly positive sentiment, celebrating significant corporate and operational milestones, including a Nasdaq uplisting and a large number of successful surgeries without complications. The outlook for global expansion is also positive.

Positives

• Uplisting of common stock to Nasdaq in April 2025, a major milestone enhancing visibility and access to capital markets.
• Successful completion of over 4,000 robotic surgeries with the SSi Mantra system, demonstrating clinical efficacy and safety.
• Zero reported complications, injuries, or mortalities in any of the 4,000+ surgeries performed, highlighting the system's safety profile.
• Growing acceptance of the SSi Mantra among physicians across India and in six other countries, indicating market traction.
• Strategic plans for global expansion into new significant markets, including the European Union and the United States.
• The SSi Mantra system is positioned as a cost-effective and differentiated surgical robotic solution, aiming to increase accessibility to robotic surgery.

Risks

• Forward-looking statements contained in the report involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied.
• Specific risks and uncertainties are detailed in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission.

Future Outlook

The Company remains on track to introduce the SSi Mantra system in new markets around the world, including the European Union and the United States, with the aim of enabling advanced, accessible, and affordable robotic surgery for a broader segment of patients in need.

Management Comments

• "This event commemorates the April 2025 uplisting of SS Innovations common stock to Nasdaq, a major milestone that would not have been possible without the dedication and hard work of our entire team in developing the SSi Mantra, a cost-effective, differentiated surgical robotic system of premier quality." Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer.
• "We also are celebrating the successful completion of more than 4,000 robotic surgeries by the SSi Mantra across over one hundred types of surgeries without any complications, injuries or mortalities – a notable milestone that we surpassed last month." Dr. Sudhir Srivastava.
• "We are encouraged by the growing acceptance of the SSi Mantra among physicians across India and in six other countries and remain on track to introduce the system in new markets around the world, including the European Union and the United States." Dr. Sudhir Srivastava.
• "Through growing global deployment of the SSi Mantra, we aim to enable advanced, accessible, and affordable robotic surgery for a broader segment of patients in need." Dr. Sudhir Srivastava.

Industry Context

SS Innovations operates in the high-growth surgical robotics industry, aiming to differentiate itself by offering a cost-effective and accessible robotic surgery solution. This strategy positions the company to potentially expand market penetration beyond traditional high-income healthcare settings, challenging established players by addressing the significant barrier of affordability. Their global expansion plans, particularly into the EU and US, indicate a strategic move to compete on a broader scale.

Comparison to Industry Standards

• The SSi Mantra system's achievement of over 4,000 surgeries without complications, injuries, or mortalities provides strong clinical validation, aligning with the high safety standards expected from leading robotic surgery platforms like Intuitive Surgical's da Vinci system.
• The company's focus on providing a 'cost-effective' and 'affordable' surgical robotic system directly addresses a key limitation of current market leaders, whose systems often involve substantial capital expenditure and per-procedure costs, potentially expanding the market to a broader global patient population.
• The expansion into six countries beyond India and planned entry into the European Union and the United States demonstrates a global ambition comparable to major medical device companies, but with a distinct value proposition centered on accessibility and affordability.

Stakeholder Impact

• Shareholders: Benefit from increased visibility and potential liquidity due to the Nasdaq uplisting, and enhanced investor confidence from positive operational milestones.
• Patients: Gain access to advanced, affordable robotic surgery through the SSi Mantra system, potentially improving healthcare outcomes.
• Physicians/Healthcare Providers: Provided with a cost-effective, user-friendly surgical robotic system that has demonstrated clinical safety and efficacy.
• Employees: Recognition for their dedication and hard work in achieving significant corporate and operational milestones.

Next Steps

• Ring the Nasdaq Opening Bell on June 3, 2025.
• Introduce the SSi Mantra system in new global markets, including the European Union and the United States.
• Continue growing global deployment of the SSi Mantra to enable advanced, accessible, and affordable robotic surgery.

Key Dates

Recommendation

Keywords

Surgical robotics, SSi Mantra, Robotic surgery, Medical technology, Healthcare, Nasdaq, SS Innovations, SSII, Surgical instruments, SSi Mudra